
Oseltamivir, an antiviral agent for the treatment of influenza, should be started within 48 hours of symptom onset for most hospitalized patients and outpatients who are suspected of H1N1 or other strains of the flu, according to a recent report in the American Journal of Health-System Pharmacy.